Results 31 to 40 of about 2,638,617 (370)

Brain edema : a valid endpoint for measuring hepatic encephalopathy? [PDF]

open access: yes, 2016
Hepatic encephalopathy (HE) is a major complication of liver failure/disease which frequently develops during the progression of end-stage liver disease.
Bémeur, Chantal   +5 more
core   +1 more source

Is Addiction a Brain Disease? [PDF]

open access: yesNeuroethics, 2016
Where does normal brain or psychological function end, and pathology begin? The line can be hard to discern, making disease sometimes a tricky word. In addiction, normal 'wanting' processes become distorted and excessive, according to the incentive-sensitization theory.
openaire   +3 more sources

Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update

open access: yesCells, 2020
Neuroinflammation and cell death are among the common symptoms of many central nervous system diseases and injuries. Neuroinflammation and programmed cell death of the various cell types in the brain appear to be part of these disorders, and ...
Jasmina Dimitrova-Shumkovska   +2 more
doaj   +1 more source

A model of brain morphological changes related to aging and Alzheimer's disease from cross-sectional assessments [PDF]

open access: yes, 2019
In this study we propose a deformation-based framework to jointly model the influence of aging and Alzheimer's disease (AD) on the brain morphological evolution.
Ayache, Nicholas   +4 more
core   +4 more sources

Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers

open access: yesNature Communications, 2022
In this work, Louros et al. uncover a rule book for interactions of amyloids with other proteins. This grammar was shown to promote cellular spreading of tau aggregates in cells, but can also be harvested to develop structure-based aggregation blockers.
Nikolaos Louros   +12 more
doaj   +1 more source

Application of Time-Aware PC algorithm to compute Causal Functional Connectivity in Alzheimer's Disease from fMRI data [PDF]

open access: yesarXiv, 2023
Functional Connectivity between brain regions is known to be altered in Alzheimer's disease, and promises to be a biomarker for early diagnosis of the disease. While several approaches for functional connectivity obtain an un-directed network representing stochastic associations (correlations) between brain regions, association does not necessarily ...
arxiv  

Alois Alzheimer and vascular brain disease: Arteriosclerotic atrophy of the brain. [PDF]

open access: yes, 2015
Alois Alzheimer is best known for his description of neurofibrillary changes in brain neurons of a demented patient, identifying a novel disease, soon named after him by Kraepelin.
Engelhardt, Eliasz, Grinberg, Lea T
core   +2 more sources

Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain

open access: yesEMBO Molecular Medicine, 2023
Cognitive decline is a common pathological outcome during aging, with an ill‐defined molecular and cellular basis. In recent years, the concept of inflammaging, defined as a low‐grade inflammation increasing with age, has emerged.
Pierre Lemaitre   +10 more
doaj   +1 more source

Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease

open access: yesFrontiers in Neurology, 2021
Parkinson's disease (PD) is a movement disorder attributed to the loss of dopaminergic (DA) neurons mainly in the substantia nigra pars compacta. Motor symptoms include resting tremor, rigidity, and bradykinesias, while non-motor symptoms include ...
Albert Frank Magnusen   +4 more
doaj   +1 more source

A fruitful fly forward : the role of the fly in drug discovery for neurodegeneration [PDF]

open access: yes, 2014
AD, Alzheimer’s disease; APP, amyloid precursor protein; BBB, blood brain barrier; GFP, green fluorescent protein; HTS, high-throughput screening; HD, Huntington’s disease; LB, Lewy bodies; PD, Parkinson’s disease; PolyQ, Polyglutamine; RNAi, RNA ...
Briffa, Michelle   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy